Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Zhang, Xu-Huaa; 1 | Zhang, Yueb; 1 | Xie, Wen-Pengb | Sun, De-Shengc | Zhang, Yong-Kuid; * | Hao, Yan-Ked | Tan, Guo-Qingd
Affiliations: [a] Department of Clinical Chemistry, The Second Hospital of Shandong University, Jinan, Shandong, China | [b] Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China | [c] Department of Orthopedics, The People's Hospital of Penglai City, Penglai, Shandong, China | [d] Department of Orthopedics, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China
Correspondence: [*] Corresponding author: Yong-Kui Zhang, Department of Orthopedics, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, 16,369 Jingshi Road, Jinan 250014, Shandong, China. E-mail:xiaoniu0928@163.com
Note: [1] Contributed equally to the work.
Abstract: BACKGROUND: As one of the endoplasmic reticulum proteins, calreticulin (CRT) plays a significant role in the body, and it has been used by many researchers as a target for anti-tumor therapy. OBJECTIVE: The main purpose of the present study was to study expression of CRT of human osteosarcoma, and analyze the distinctions between normal and tumor tissues, pre- and post-chemotherapy patients, and metastatic and non-metastatic tumors in respect to this expression. METHODS: Immunofluorescent staining was used in order to investigate expression of CRT in diverse tissues. The whole RNA and proteins were extracted from the crushed tissues and used in the reverse transcription polymerase chain reaction (RT-PCR) and western blotting analysis. RESULTS: The present study detected expression of CRT in patients with osteosarcoma and revealed a higher expression level in normal tissues surrounding tumors compared with tumor tissues, in the non-metastasis group compared with the metastasis group, and in the chemotherapy group compared with the non-chemotherapy group. CONCLUSIONS: These results could indicate a brand-new biological marker which may be applied to estimate the features and prognosis of osteosarcoma.
Keywords: Osteosarcoma, Calreticulin, immunofluorescent staining, reverse transcription polymerase chain reaction, western blot analysis
DOI: 10.3233/CBM-160266
Journal: Cancer Biomarkers, vol. 18, no. 4, pp. 405-411, 2017
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl